Weight-loss medicine may soon move beyond people and into veterinary care, with startups testing GLP-1 treatments for overweight cats. The interest points to a growing pet-health market where owners are spending more on products and care aimed at improving their animals’ quality of life.
The push comes as excess weight remains a common challenge for many house cats. The story spotlights Felix, a five-year-old Maine Coon in Dallas, as one example of a pet that loves food and has struggled to slim down despite efforts at home. Cases like that are helping fuel interest in new options beyond diet changes alone.
Alongside drug development, large pet-food companies are also leaning further into longevity products. That signals a broader shift in the industry, from basic feeding toward health-focused offerings tied to aging, wellness and prevention.
Even so, these treatments are still in the testing stage rather than being a standard solution for most pets. The trend nonetheless shows how pet care is increasingly following human health patterns, with obesity and long-term wellness becoming major areas of focus.
